 Los Angeles, California--Newsfile Corp. - December 7, 2020 - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Reata Pharmaceuticals, Inc. Reata or the Company NASDAQ: RETA for violations of 10b and 20a of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Companys securities between October 15, 2019 and August 7, 2020,... 